FDA approves clinical testing of stem cell-based myopia treatment

02/13/2013 | Pharmaceutical Business Review Online

Advanced Cell Technology's clinical partner, the University of California, Los Angeles, obtained FDA approval for a trial to evaluate the safety of subretinal implantation of human embryonic stem cell-derived cells as a therapy for severe myopia. The study could include 12 patients.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN